241 related articles for article (PubMed ID: 18542002)
1. Myostatin is a procachectic growth factor during postnatal myogenesis.
McFarlane C; Sharma M; Kambadur R
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):422-7. PubMed ID: 18542002
[TBL] [Abstract][Full Text] [Related]
2. Targeting myostatin for therapies against muscle-wasting disorders.
Tsuchida K
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy with anabolic growth factors to prevent muscle atrophy.
Schakman O; Thissen JP
Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):207-13. PubMed ID: 16607118
[TBL] [Abstract][Full Text] [Related]
4. The possible role of myostatin in skeletal muscle atrophy and cachexia.
Jespersen J; Kjaer M; Schjerling P
Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
[TBL] [Abstract][Full Text] [Related]
5. Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice.
Liu CM; Yang Z; Liu CW; Wang R; Tien P; Dale R; Sun LQ
Gene Ther; 2008 Feb; 15(3):155-60. PubMed ID: 18033313
[TBL] [Abstract][Full Text] [Related]
6. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
Gelato M; McNurlan M; Freedland E
Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
[TBL] [Abstract][Full Text] [Related]
7. Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects.
Joulia-Ekaza D; Cabello G
Exp Cell Res; 2006 Aug; 312(13):2401-14. PubMed ID: 16793037
[TBL] [Abstract][Full Text] [Related]
8. The myostatin gene: physiology and pharmacological relevance.
Joulia-Ekaza D; Cabello G
Curr Opin Pharmacol; 2007 Jun; 7(3):310-5. PubMed ID: 17374508
[TBL] [Abstract][Full Text] [Related]
9. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
[TBL] [Abstract][Full Text] [Related]
10. Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases.
Tobin JF; Celeste AJ
Curr Opin Pharmacol; 2005 Jun; 5(3):328-32. PubMed ID: 15907921
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
12. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.
Matsakas A; Diel P
Int J Sports Med; 2005 Mar; 26(2):83-9. PubMed ID: 15726494
[TBL] [Abstract][Full Text] [Related]
13. Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene.
Grobet L; Pirottin D; Farnir F; Poncelet D; Royo LJ; Brouwers B; Christians E; Desmecht D; Coignoul F; Kahn R; Georges M
Genesis; 2003 Apr; 35(4):227-38. PubMed ID: 12717734
[TBL] [Abstract][Full Text] [Related]
14. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism.
McFarlane C; Plummer E; Thomas M; Hennebry A; Ashby M; Ling N; Smith H; Sharma M; Kambadur R
J Cell Physiol; 2006 Nov; 209(2):501-14. PubMed ID: 16883577
[TBL] [Abstract][Full Text] [Related]
15. Myostatin inhibition: a potential performance enhancement strategy?
Fedoruk MN; Rupert JL
Scand J Med Sci Sports; 2008 Apr; 18(2):123-31. PubMed ID: 18248537
[TBL] [Abstract][Full Text] [Related]
16. Myostatin expression in muscular dystrophies and mitochondrial encephalomyopathies.
Castro-Gago M; Blanco-Barca MO; Eiris-Puñal J; Carneiro I; Arce VM; Devesa J
Pediatr Neurol; 2006 Apr; 34(4):281-4. PubMed ID: 16638502
[TBL] [Abstract][Full Text] [Related]
17. Induction of cachexia in mice by systemically administered myostatin.
Zimmers TA; Davies MV; Koniaris LG; Haynes P; Esquela AF; Tomkinson KN; McPherron AC; Wolfman NM; Lee SJ
Science; 2002 May; 296(5572):1486-8. PubMed ID: 12029139
[TBL] [Abstract][Full Text] [Related]
18. Myostatin: Regulator of muscle wasting in heart failure and treatment target for cardiac cachexia.
Springer J; Adams V; Anker SD
Circulation; 2010 Jan; 121(3):354-6. PubMed ID: 20065169
[No Abstract] [Full Text] [Related]
19. Proteolytic processing of myostatin is auto-regulated during myogenesis.
McFarlane C; Langley B; Thomas M; Hennebry A; Plummer E; Nicholas G; McMahon C; Sharma M; Kambadur R
Dev Biol; 2005 Jul; 283(1):58-69. PubMed ID: 15975431
[TBL] [Abstract][Full Text] [Related]
20. Cancer cachexia.
Tisdale MJ
Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
